Open navigation
Search

Intellectual Property

Latest

  • EU Pharmaceutical Package: what the Council’s revised texts mean for companies
    02 Oct 2026 8 min read
  • Joining the Dots – Part 4: Deadlines announced
    01 Oct 2026 4 min read
  • CJEU rules on when the ‘due cause’ defence falls flat (pack)
    23 Sep 2026 5 min read
  • CMS Wistrand advises S-Invest Trading AB on the acquisition of Växthuset Linds in Visby
    01 Sep 2026 1 min read
  • A complex question: defining the SPC product in Accord v Novartis [2026] EWHC 2127 (Pat)
    21 Aug 2026 7 min read
  • EU Pharma Package: Regulatory data and market protection
    14 Aug 2026 13 min read
  • EU Pharmaceutical Package: No Reset for Parallel Imports
    05 Aug 2026 10 min read
  • How the EU Pharma Package will reshape orphan drug regulation
    28 Jul 2026 8 min read
  • Geo-Blocking, VPNs and Territorial Reach – the CJEU’s Ruling in Anne Frank Fonds v Anne Frank Stichting
    23 Jul 2026 6 min read
  • The extension of the Bolar exemption in the EU Pharma Package
    21 Jul 2026 8 min read
  • Streaming, bitstreams and patent exhaustion: when VDP licensing demands go too far
    21 Jul 2026 12 min read
  • Encoder claims and standard essentiality: why categorical exclusions miss the mark
    16 Jul 2026 9 min read
  • Stability as strategy: The UK’s regulatory position in the wake of the EU Pharmaceutical Package
    15 Jul 2026 7 min read
  • UK Clinical Trial Transparency and Patent Strategy
    13 Jul 2026 12 min read

Safeguarding intellectual property involves strategic considerations. Determining the rights to intangible creations developed during employment and effectively managing disputes over intellectual property rights are crucial aspects.

Support to protect your intellectual property rights

At CMS Wistrand, we employ a clear and precise tone in addressing these critical questions. Our active support extends to assisting clients in establishing and commercializing intellectual property rights, encompassing trademarks, copyright, design protection, inventions, company secrets, and know-how. Our expertise spans negotiating and drafting various agreements, including collaboration agreements, R&D agreements, license agreements, design and pattern agreements, co-existence agreements, and other contracts related to intellectual property rights.

Our advisory services cover key areas:

  • Contract management for establishing, transferring, and licensing intellectual property
  • Intellectual property, know-how, and company secrets
  • Development of guidelines and policies for protecting and licensing intangible assets
  • Addressing intellectual property issues in corporate and movable transfers, including due diligence
  • Negotiating with authorities such as the Swedish Patent and Registration Office, EUIPO, and WIPO
  • Managing disputes concerning intellectual property rights, know-how, and company secrets, including infringement investigations and safeguards.
Awards & Recognitions
01 –
  • Quote
    Hands-on, pragmatic and a full-service offering providing broad competence with edge where needed. The lawyers that I have worked with showcase a combination of technical expertise, business pragmatism and interpersonal skills.
    Client Feedback - Legal 500

Intellectual Property Insights

EU Pharmaceutical Package: what the Council’s revised texts mean for companies

EU Pharmaceutical Package: what the Council’s revised texts mean for companies

02 Oct 2026 8 min read
Joining the Dots – Part 4: Deadlines announced

Joining the Dots – Part 4: Deadlines announced

01 Oct 2026 4 min read
CJEU rules on when the ‘due cause’ defence falls flat (pack)

CJEU rules on when the ‘due cause’ defence falls flat (pack)

23 Sep 2026 5 min read
A complex question: defining the SPC product in Accord v Novartis [2026] EWHC 2127 (Pat)

A complex question: defining the SPC product in Accord v Novartis [2026] EWHC 2127 (Pat)

21 Aug 2026 7 min read
EU Pharma Package: Regulatory data and market protection

EU Pharma Package: Regulatory data and market protection

14 Aug 2026 13 min read
EU Pharmaceutical Package: No Reset for Parallel Imports

EU Pharmaceutical Package: No Reset for Parallel Imports

05 Aug 2026 10 min read
How the EU Pharma Package will reshape orphan drug regulation

How the EU Pharma Package will reshape orphan drug regulation

28 Jul 2026 8 min read
Geo-Blocking, VPNs and Territorial Reach – the CJEU’s Ruling in Anne Frank Fonds v Anne Frank Stichting

Geo-Blocking, VPNs and Territorial Reach – the CJEU’s Ruling in Anne Frank Fonds v Anne Frank Stichting

23 Jul 2026 6 min read

Events

  • 10 Sep 2026 - 04 Nov 2026
  • 30 Sep 2026 - 19 Nov 2026

Local market knowledge. Global outlook

We provide future-facing legal advice to help your organisation thrive. Combining local market knowledge and a global perspective, and with lawyers in locations worldwide, your organisation benefits from the expertise it needs, even across borders.

About CMS
People across CMS Find a Lawyer
10,000+ Staff
7,400+ Lawyers
Locations across CMS Find an office
50+ Countries
90+ Offices
22 Member firms
Back to top Back to top
Opens in new window